curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
- Evidence strength: moderate.Findingreplicated ×3
“Insulin resistance, measured via HOMA-IR, was significantly lower in the curcumin-treated group than in the placebo group at all follow-up assessments (3, 6, 9, and 12 months; Supplementary Figure S3I).”
Quoted verbatim from The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.. - Study
- RCT
- Dose
- curcuminoid extract 250 mg per capsule, three capsules twice daily after meals (six capsules a day) for 12 months
- Population
- Thai adults with type 2 diabetes diagnosed within the past year, well controlled (HbA1c below 6.5%), BMI 23 or above; difference at 3, 6, 9 and 12 months
The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.2024PMID:3912532210.3390/nu16152441Industry fundedPermalink
To cite this finding: https://catalystproject.ai/e/01M5RWYZ7EEKP111SZ39TQ3NZG